Cannon Global Investment Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,000
Closed -$76K 104
2025
Q1
$76K Sell
10,000
-15,500
-61% -$130K 0.13% 73
2024
Q4
$245K Buy
25,500
+500
+2% +$3.9K 0.53% 67
2024
Q3
$148K Buy
25,000
+8,000
+47% +$53K 0.24% 63
2024
Q2
$118K Buy
+17,000
New +$120K 0.55% 34
2021
Q2
Sell
-16,500
Closed -$170K 85
2021
Q1
$170K Buy
+16,500
New +$159K 0.29% 85

Other funds holding MDXG

Cannon Global Investment Management's MDXG Position: Q2 2025 in Review

Cannon Global Investment Management sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 10,000 shares — an estimated $76K sold.

Cannon Global Investment Management first reported a position in MDXG in Q1 2021 and held it in 5 quarters. The position peaked at $245K in Q4 2024. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.

  • Cannon Global Investment Management reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
  • Cannon Global Investment Management sold 10,000 MiMedx Group shares in Q2 2025, an estimated $76K.
  • Cannon Global Investment Management first reported a position in MiMedx Group in Q1 2021 and held it in 5 quarters.
  • Cannon Global Investment Management's MiMedx Group position peaked at $245K in Q4 2024.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.

Based on Cannon Global Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.